RECON

Welcome to the Brand page for “RECON”, which is offered here for Pharmaceuticals, immunomodulators; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; synthetic peptides for the treatment of cancer; and vaccine preparations;.

Its status is currently believed to be active. Its class is unavailable. “RECON” is believed to be currently owned by “BioNTech US Inc.”


Owner:
BIONTECH US INC.
Owner Details
Description:
Pharmaceuticals, immunomodulators; anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; synthetic peptides for the treatment of cancer; and vaccine preparations;
Categories: PHARMACEUTICALS